2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI?是时候来Springer出书了! |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | AMERICAN JOURNAL OF NEPHROLOGY AM J NEPHROL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.6
52人评分
我要评分
声誉 7.6 影响力 5.2 速度 9.1 | |||||||||||||||||
| 期刊ISSN | 0250-8095 | 安装APP,查看期刊最新消息
| ||||||||||||||||
| E-ISSN | 1421-9670 | |||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:3.6 | |||||||||||||||||
| 2025-2026自引率 | 2.6%点击查看自引率趋势图 | |||||||||||||||||
| 五年IF (数据来源于网友提供) | 4.196数据由网友[retrodaze611]收集提供 | |||||||||||||||||
| h-index | 75 | |||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||
| 期刊简介 |
| |||||||||||||||||
| 期刊官方网站 | https://karger.com/AJN | |||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||
| 期刊投稿网址 | https://karger.com/AJN/pages/submission | |||||||||||||||||
| 作者指南网址 | https://karger.com/ajn/pages/guidelines | |||||||||||||||||
| 该期刊中国学者近期发文 - New | A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Desidustat's Efficacy and Safety in Non-Dialysis Chronic Kidney Disease Patients with Anemia Author: Ma, Jie; Yang, Xiangdong; Xiao, Xiaoyan; Sun, Changyou; Zhang, Qinghong; Wang, Caili; Xu, Yan; Zhao, Jianrong; Yang, Aicheng; Cheng, Hong; Chen, Menghua; Chen, Wenli; Zheng, Zhihua; Shi, Yongjun; Zhao, Zhanzheng; Yang, Zhenhua; Yang, Lin; Yao, Li; Zhong, Xiaoshi; Deng, Yilan; Xiong, Zuying; Yang, Xiaoping; Zhang, Chunjiang; Xie, Weiji; Yin, Aiping; Zhou, Hua; Bi, Weihong; Li, Wenbin; Wang, Junxia; Li, Suhua; Yin, Yuanyuan; Li, Xuemei Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000551113 Hypoxia-Inducible Factor-1α Drives Cellular Senescence via Autophagy Activation to Promote Acute Kidney Injury-to-CKD Transition Author: Zhang, Manzhu; Li, Lingxu; Mao, Xinyue; Yun, Xiaoying; Wu, Meiting; Wang, Chang; Li, Bing Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000551542 Canagliflozin Reduces Proteinuria and Mitochondrial Fission in Membranous Nephropathy Rats via CAV1/PKA/DRP1 Inhibition Author: Lv, Xin; Cui, Liling; Liu, Hongyan; Wei, Hongkun; Xu, Jia; He, Dandan; Yan, Caiyun; Shao, Wen Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550928 The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis-Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (Recombinant Human Erythropoietin), Open-Label Study - The ENARODIAL Study Author: Wu, Haishan; Ai, Zhen; Liu, Aiying; Ye, Hong; Sun, Changyou; Yang, Aicheng; Chen, Wenli; Zheng, Zhihua; Wang, Caili; Li, Yuehong; Cao, Ning; Wang, Cheng; Xia, Yuou; Cheng, Hong; Luo, Ping; Yang, Qiongqiong; Yan, Yuehong; Zhou, Hua; Mao, Nan; Xiong, Zibo; Liu, Bicheng; Hong, Daqing; Chen, Qingping; Liang, Bo; Luo, Qun; Wang, Yu; Shi, Yongjun; Chen, Xiaonong; Zhou, Li; Yan, Tiekun; Zhu, Bin; Wang, Jianwen; Chen, Menghua; Zhu, Yongjun; Guan, Tianjun; Wang, Song; Mu, Shengmei; Chen, Yuanyuan; Lian, Xiaojuan; Liu, Zichen; Xu, Yuanwen; Chen, Wei Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550548 | |||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足AMERICAN JOURNAL OF NEPHROLOGY的语言要求,还能让AMERICAN JOURNAL OF NEPHROLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被AMERICAN JOURNAL OF NEPHROLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||
| 通讯方式 | KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009 | |||||||||||||||||
| 出版商 | S. Karger AG | |||||||||||||||||
| 涉及的研究方向 | 医学-泌尿学与肾脏学 | |||||||||||||||||
| 出版国家或地区 | SWITZERLAND | |||||||||||||||||
| 出版语言 | English | |||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||
| 出版年份 | 1981 | |||||||||||||||||
| 年文章数 | 99点击查看年文章数趋势图 | |||||||||||||||||
| Gold OA文章占比 | 15.92% | |||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 84.85% | |||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0250-8095%5BISSN%5D | |||||||||||||||||
| 平均审稿速度 | 网友分享经验: 偏慢,4-8周 | |||||||||||||||||
| 平均录用比例 | 网友分享经验: 容易 | |||||||||||||||||
| APC文章处理费信息 | 版面费:Each increment of 5000 character count equivalent above 20,000 character count equivalent will be charged at CHF 495.00 / USD 590.00 / EUR 540.00. | |||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在AMERICAN JOURNAL OF NEPHROLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||
| 收稿范围 | 期刊官网数据: Original Research - Transplantation: Manuscripts under this section include both basic and translational topics. Original experimental data are preferred; however, other content will be considered. - Patient-oriented, Translational Research - Laboratory Investigations In-Depth Topic Reviews In-Depth Topic Reviews are invited or agreed upon by the senior editors. An Abstract is required and should be divided into Background, Summary and Key Messages. Invited Reviews incur no charge. If an individual or group has an idea for an in-depth review topic, they should also submit an outline as a word document including 1) relevance of review; 2) authors with their institution and areas of expertise; and 3) outline of review headings. The topic will be discussed with senior editors for a decision regarding acceptability. If acceptable, it will proceed to peer review; however, this does not assure acceptance of the final review article. Novel Research Findings The focus of these papers is to highlight novel findings as a part of a larger, more comprehensive study. These findings need to be both innovative and potentially helpful to other researchers without compromising the subsequent publication of the author’s primary study. The data can focus on mechanisms related to disease or aspects of clinical management that might extend knowledge and facilitate the research of other investigators. Papers should be maximum 2500 words and 15 references with one figure and Table maximum. They should have an abstract of 150 words maximum in the same format as original research as well. (Invited) Perspective This section is devoted to challenges to either evidence based opinion of either existing ideas or new ideas based on a strong hypothesis with some preliminary evidence. The letter cannot be longer than 2000 words and should contain no more than 20 references. Maximum one figure or table is allowed. No Abstract is required. | |||||||||||||||||
| 收录体裁 | 期刊官网数据: Research Article; Review Article; Systematic Review; Brief Report; Commentary; Editorial; Letter; Methods Article; Guidelines; | |||||||||||||||||
| 编辑信息 | Editor-in-Chief David C. Wheeler – University College London, London, UK Managing Editor Sam Bose – Karger Publishers, Basel, Switzerland Associate Editor Jonathan Barratt – University of Leicester, Leicester, UK Rikke Borg – University of Copenhagen, Copenhagen, Denmark Glenn Chertow – Stanford University School of Medicine, Palo Alto, CA, US Alejandro R. Chade – University of Missouri-Columbia, Columbia, MO, USA Steven Fishbane – Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA Sharlene A Greenwood – King's College Hospital NHS Trust and King's College London, London, UK Manfred Hecking – Medical University of Vienna, Vienna, Austria William G. Herrington – Nuffield Department of Population Health, University of Oxford and Oxford University Hospitals NHS Foundation Trust, Oxford, UK Maria V. Irazabal – Mayo Clinic, Rochester, MN, USA Jolanta Malyszko – Medical University of Warsaw, Warsaw, Poland Finnian R. Mc Causland – Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA Christopher W McIntyre – Western University, London, Ontario, Canada Brendon Neuen – The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia Amy Jayne McKnight – Queen's University, Belfast, UK Michele Provenzano – University of Calabria, Rende, Italy Michael R. Rudnick – University of Pennsylvania, Philadelphia, PA, USA Alan Salama – Royal Free Hospital NHS Foundation Trust, and University College London, London, UK Pantelis Sarafidis – Aristotle University of Thessaloniki, Thessaloniki, Greece Smeeta Sinha – Northern Care Alliance NHS Foundation Trust, Salford, UK Maarten Taal – School of Medicine, University of Nottingham, Nottingham, UK Marc G. Vervloet – Radboud University Medical Center, Nijmegen, The Netherlands Hong Zhang – Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China Carmine Zoccali – Renal Research Institute, New York, NY, USA; Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy; Associazione Ipertensione Nefrologia Trapianto Renal (IPNET), c/o Nefrologia, Grande Ospedale Metropolitano, Reggio Calabria, Italy | |||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Desidustat's Efficacy and Safety in Non-Dialysis Chronic Kidney Disease Patients with Anemia Author: Ma, Jie; Yang, Xiangdong; Xiao, Xiaoyan; Sun, Changyou; Zhang, Qinghong; Wang, Caili; Xu, Yan; Zhao, Jianrong; Yang, Aicheng; Cheng, Hong; Chen, Menghua; Chen, Wenli; Zheng, Zhihua; Shi, Yongjun; Zhao, Zhanzheng; Yang, Zhenhua; Yang, Lin; Yao, Li; Zhong, Xiaoshi; Deng, Yilan; Xiong, Zuying; Yang, Xiaoping; Zhang, Chunjiang; Xie, Weiji; Yin, Aiping; Zhou, Hua; Bi, Weihong; Li, Wenbin; Wang, Junxia; Li, Suhua; Yin, Yuanyuan; Li, Xuemei Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000551113 PubMed DOI |
| 2. | Hypoxia-Inducible Factor-1α Drives Cellular Senescence via Autophagy Activation to Promote Acute Kidney Injury-to-CKD Transition Author: Zhang, Manzhu; Li, Lingxu; Mao, Xinyue; Yun, Xiaoying; Wu, Meiting; Wang, Chang; Li, Bing Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000551542 PubMed DOI |
| 3. | Canagliflozin Reduces Proteinuria and Mitochondrial Fission in Membranous Nephropathy Rats via CAV1/PKA/DRP1 Inhibition Author: Lv, Xin; Cui, Liling; Liu, Hongyan; Wei, Hongkun; Xu, Jia; He, Dandan; Yan, Caiyun; Shao, Wen Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550928 PubMed DOI |
| 4. | The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis-Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (Recombinant Human Erythropoietin), Open-Label Study - The ENARODIAL Study Author: Wu, Haishan; Ai, Zhen; Liu, Aiying; Ye, Hong; Sun, Changyou; Yang, Aicheng; Chen, Wenli; Zheng, Zhihua; Wang, Caili; Li, Yuehong; Cao, Ning; Wang, Cheng; Xia, Yuou; Cheng, Hong; Luo, Ping; Yang, Qiongqiong; Yan, Yuehong; Zhou, Hua; Mao, Nan; Xiong, Zibo; Liu, Bicheng; Hong, Daqing; Chen, Qingping; Liang, Bo; Luo, Qun; Wang, Yu; Shi, Yongjun; Chen, Xiaonong; Zhou, Li; Yan, Tiekun; Zhu, Bin; Wang, Jianwen; Chen, Menghua; Zhu, Yongjun; Guan, Tianjun; Wang, Song; Mu, Shengmei; Chen, Yuanyuan; Lian, Xiaojuan; Liu, Zichen; Xu, Yuanwen; Chen, Wei Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550548 PubMed DOI |
| 5. | A Comparative Analysis of Left Ventricular Myocardial Work in Patients with Diabetic and Non-Diabetic Kidney Disease after Peritoneal Dialysis Author: Wan, Minjie; Yi, Chunyan; Wang, Yan; Qiu, Yagui; Yu, Jianwen; Lin, Jianxiong; Chen, Wei; Mao, Haiping; Yang, Xiao; Yao, Fengjuan; Liu, Donghong; Guo, Qunying; Liu, Yanqiu Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550324 PubMed DOI |
| 6. | Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial Author: Badve, Sunil V.; Al Ammari, Maha; Anderson, Craig S.; Billot, Laurent; Bompoint, Severine; Collister, David; De Vriese, An S.; Eikelboom, John W.; Flahault, Adrien; Garg, Amit X.; Ha, Jeffrey T.; Heerspink, Hiddo J. L.; Jardine, Meg J.; Jesudason, Shilpanjali; Jha, Vivekanand; Jun, Min; Landrigan, Jenny; Liew, Adrian; Lin, Enmoore; Lv, Jicheng; Mark, Patrick B.; Menne, Jan; Monaghan, Helen; Mushahar, Lily; Patel, Anushka; Pilmore, Helen; Perkovic, Vlado; Ramachandran, Raja; Rossignol, Patrick; Shaman, Ahmed; Skhiri, Habib; Walsh, Michael; Wheeler, David C.; Wong, Muh Geot; Zuo, Li; Gallagher, Martin Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550796 PubMed DOI |
| 7. | Anti-Phospholipase A2 Receptor Antibody Trajectories for Predicting Prognosis in Patients with Phospholipase A2 Receptor-Associated Membranous Nephropathy Author: Gong, Siwen; Chen, Dacheng; Xu, Feng; Li, Zhe; Li, Aijuan; Liu, Zhihong; Zeng, Mengyao Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550352 PubMed DOI |
| 8. | Urinary Cytokeratin 20 Predicts Severe Acute Kidney Injury and Major Adverse Kidney Events in Adults Undergoing Cardiac Surgery Author: Ma, Rui; Ouyang, Han; Chen, Chunbo; Xu, Xin; Tian, Jianwei; Zhong, Ruhe; Zha, Yan; Teng, Siyuan; Li, Guisen; Liu, Huafeng; Yang, Xiaobing; Hou, Fan Fan Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1159/000546159 PubMed DOI |
| 9. | Utilizing Deep Learning to Identify Electron-Dense Deposits in Renal Biopsy Electron Microscopy Images Author: Zhu, Shuangshuang; Luo, Bei; Lai, Sendong; Yue, Shuling; Yang, Guang; Song, Zhen; Xu, Xiaomeng; Gui, Yangyang; Chen, Anlan; Yu, Hongmei; Liu, Yanqiu; Liu, Hongyu; Yang, Chao; Zheng, Lei Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1159/000546131 PubMed DOI |
| 10. | Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy Author: Li, Huixian; Jin, Li; Xie, Xinfang; Sun, Jiping; Niu, Dan; Feng, Jie; Xu, Guiqing; Zhang, Xiaotian; Khalaf, Abdulrahman Majeed S.; Lu, Wanhong Journal: AMERICAN JOURNAL OF NEPHROLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1159/000545995 PubMed DOI |
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共17条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室